Evidence map›Paper›PMID 35034101›Full record

ArticleCell death and differentiation2022

TLR4 downregulation by the RNA-binding protein PUM1 alleviates cellular aging and osteoarthritis.

Dong Suk Yoon, Kyoung-Mi Lee, Yoorim Choi, Eun Ae Ko, Na-Hyun Lee, Sehee Cho, Kwang Hwan Park, Jung-Hwan Lee, Hae-Won Kim, Jin Woo Lee

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Listerin Alleviates Alzheimer's Disease through IRE1-mediated Decay of TLR4 mRNA.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Emerging Therapy in Osteoarthritis: Mesenchymal Stem Cells, Secretomes, and Using Hydrogels to Enhance Efficacy.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2025
    Review
  19. Inflammation-triggered Gli1Cellular & molecular immunology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Dong Suk YoonDepartment of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, 03722, South Korea.ORCID http://orcid.org/0000-0001-5945-5569
Kyoung-Mi LeeDepartment of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, 03722, South Korea.
Yoorim ChoiDepartment of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, 03722, South Korea.
Eun Ae KoDepartment of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, 03722, South Korea.
Na-Hyun LeeInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, 31116, South Korea.ORCID http://orcid.org/0000-0002-0931-4378
Sehee ChoDepartment of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, 03722, South Korea.
Kwang Hwan ParkDepartment of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, 03722, South Korea.
Jung-Hwan LeeInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, 31116, South Korea.
Hae-Won KimInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, 31116, South Korea. kimhw@dku.edu.ORCID http://orcid.org/0000-0001-6400-6100
Jin Woo LeeDepartment of Orthopaedic Surgery, Yonsei University College of Medicine, Seoul, 03722, South Korea. ljwos@yuhs.ac.ORCID http://orcid.org/0000-0002-0293-9017
Yonsei University · KRDankook University · KRYonsei University Health System · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysfunction of mRNA or RNA-binding proteins (RBPs) causes cellular aging and age-related degenerative diseases; however, information regarding the mechanism through which RBP-mediated posttranscriptional regulation affects cellular aging and related disease processes is limited. In this study, PUM1 was found to be associated with the self-renewal capacity and aging process of human mesenchymal stem cells (MSC). PUM1 interacted with the 3'-untranslated region of Toll-like receptor 4 (TLR4) to suppress TLR4 mRNA translation and regulate the activity of nuclear factor-κB (NF-κB), a master regulator of the aging process in MSCs. PUM1 overexpression protected MSCs against H

Indexed as

Cellular SenescenceOsteoarthritisRNA-Binding ProteinsToll-Like Receptor 4AnimalsDown-RegulationHumansHydrogen PeroxideInflammationInterleukin-1betaMiceNF-kappa BHydrogen PeroxideInterleukin-1betaNF-kappa BPUM1 protein, humanRNA-Binding ProteinsTLR4 protein, humanTlr4 protein, mouseToll-Like Receptor 4

Identifiers

PMID35034101
PMCPMC9287402
OpenAlexW4205990577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.